Ms. McEvoy will remain with company into the first quarter of 2024 to support the transition, according to a news release. Tim Schmid will take her place and join Johnson & Johnson’s executive committee.
Ms. McEvoy was with Johnson & Johnson for 27 years.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.